Evidence map›Paper›PMID 26573915›Full record

ReviewBMC infectious diseases2015

Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.

Luis Furuya-Kanamori, John Marquess, Laith Yakob, Thomas V Riley, David L Paterson, Niki F Foster, Charlotte A Huber, Archie C A Clements

Abstract readReview
In one paragraph

Review in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed.

  1. Trial
  2. Article
  3. Toxins · 2026
    Article
  4. Smoking andInfection and drug resistance · 2026
    Article
  5. Article
  6. The emerging view on the roles of butyrate inInfection and immunity · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pathogens (Basel, Switzerland) · 2024
    Review
  15. Article
  16. Clinical microbiology reviews · 2024
    Review
  17. Impact of the Reverse 2-Step Algorithm forOpen forum infectious diseases · 2024
    Article
  18. Reviewing theMicroorganisms · 2024
    Review
  19. Clostridioides difficile Biofilm.Advances in experimental medicine and biology · 2024
    Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luis Furuya-KanamoriResearch School of Population Health, The Australian National University, Building 62 Mills Road, Canberra, ACT 2601, Australia. luis.furuya-kanamori@anu.edu.au.
John MarquessSchool of Population Health, The University of Queensland, Herston, QLD, Australia. john.marquess@health.qld.gov.au.
Laith YakobDepartment of Disease Control, London School of Hygiene and Tropical Medicine, London, UK. laith.yakob@lshtm.ac.uk.
Thomas V RileyMicrobiology and Immunology, School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands, WA, Australia. thomas.riley@uwa.edu.au.
David L PatersonThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD, Australia. david.antibiotics@gmail.com.
Niki F FosterPathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia. niki.foster@health.wa.gov.au.
Charlotte A HuberThe University of Queensland, UQ Centre for Clinical Research, Herston, QLD, Australia. c.huber@uq.edu.au.
Archie C A ClementsResearch School of Population Health, The Australian National University, Building 62 Mills Road, Canberra, ACT 2601, Australia. director.rsph@anu.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe epidemiology of Clostridium difficile infection (CDI) has changed over the past decades with the emergence of highly virulent strains. The role of asymptomatic C. difficile colonization as part of the clinical spectrum of CDI is complex because many risk factors are common to both disease and asymptomatic states. In this article, we review the role of asymptomatic C. difficile colonization in the progression to symptomatic CDI, describe the epidemiology of asymptomatic C. difficile colonization, assess the effectiveness of screening and intensive infection control practices for patients at risk of asymptomatic C. difficile colonization, and discuss the implications for clinical practice.

methodsA narrative review was performed in PubMed for articles published from January 1980 to February 2015 using search terms 'Clostridium difficile' and 'colonization' or 'colonisation' or 'carriage'.

resultsThere is no clear definition for asymptomatic CDI and the terms carriage and colonization are often used interchangeably. The prevalence of asymptomatic C. difficile colonization varies depending on a number of host, pathogen, and environmental factors; current estimates of asymptomatic colonization may be underestimated as stool culture is not practical in a clinical setting.

conclusionsAsymptomatic C. difficile colonization presents challenging concepts in the overall picture of this disease and its management. Individuals who are colonized by the organism may acquire protection from progression to disease, however they also have the potential to contribute to transmission in healthcare settings.

Indexed as

Asymptomatic InfectionsBacterial ProteinsBacterial ToxinsClostridioides difficileClostridium InfectionsEnterotoxinsHost-Pathogen InteractionsHumansInfection ControlRisk FactorsSpores, BacterialBacterial ProteinsBacterial ToxinsEnterotoxinstcdA protein, Clostridium difficiletoxB protein, Clostridium difficile

Identifiers

PMID26573915
PMCPMC4647607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.